Navigation Links
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Date:5/25/2012

OSAKA, Japan, and SÃO JERÔNIMO, Brazil, May 25, 2012 /PRNewswire/ --



Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. (Rio Grande do Sul, Brazil, "Multilab") today jointly announced that both parties have signed an agreement whereby Takeda Farmacêutica Brasil Ltda. (São Paulo, Brazil, "Takeda Brazil"), a wholly-owned subsidiary of Takeda, aims to acquire Multilab.

Takeda expects that the transaction will be finalized by the end of 2Q of its fiscal year 2012. Under the agreement, Takeda Brazil will acquire Multilab in cash for Brazilian Real (BRL) 500 million upfront and up to BRL 40 million in additional future milestone payments to the owners of Multilab. Other financial conditions were not disclosed.

Multilab is a mid-sized pharmaceutical company with annual net revenues of BRL 140 million in 2011. Its business consists of branded generics and OTC (over-the-counter) pharmaceutical products. Retail sales for the company grew in excess of +20% p.a. over the period 2009 - 2011.

Takeda has an established presence in Brazil, manufacturing and marketing both prescription drugs as well as well-known brands such as Neosaldina® (analgesic), Eparema® (digestive) and Nebacetin® (anti-bacterial) comprising its OTC portfolio.

The acquisition of Multilab will position Takeda as one of the top ten pharmaceutical companies in Brazil(1), enriching its offering to better cater to the diverse needs of the Brazilian population. Multilab's leading products include Multigrip®, the country's best-selling OTC product for cold and flu treatment in units(2), which Takeda believes will be an excellent addition to its existing OTC product line in Brazil.

Multilab has well established distribution through regional wholesalers and small
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
2. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
3. U.S. Food and Drug Administration (FDA) Delays Review of Takedas Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
4. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
5. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
6. Takeda Completes Acquisition and Names New CEO of Nycomed
7. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
8. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
9. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
10. Takeda to Acquire Nycomed
11. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Pressure BioSciences, Inc. (OTCQB: ... has received and approved all parts required to ... has begun to manufacture the new PCT-based instrument ... be ready for shipment by mid-October and that ... at a rate of about one per week ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners ... Future to Benefit the Radiation Oncology Institute (ROI), hosted ... at Golden Gate Park in San Francisco.  ... Moore , CEO of Radiation Business Solutions, "but ... have raised over $70,000 for the ROI this year. ...
(Date:9/19/2014)... -- PCI is pleased to announce it has acquired ... provider of Clinical Trial Services and Temperature Controlled ... in the United Kingdom ... in the UK/EU to support global investigational studies ... distribution capacity, as well as consultative services for ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/20/2014)... Earlier this week, Home Depot revealed that up ... credit card information pilfered by hackers, surpassing the 40 million ... articles like this one published by Bloomberg on ... , “Most people tend to focus on how many ... to score a game,” says Joe Caruso, founder and CEO/CTO ...
(Date:9/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers. , “Fun, cool, and simple are ... says Christina Austin, CEO of Pixel Film Studios. “It has ... features easy to use controls that give the user the ... background color, color of each circle outline, the position of ...
(Date:9/20/2014)... Everett, WA (PRWEB) September 20, 2014 “Motherhood ... Health Center of Snohomish in their latest article , ... the best that you can—and that’s what we want to ... what services they need and should expect from their Family ... the following days of new motherhood. , To learn ...
(Date:9/19/2014)... Nearly 780 Risperdal lawsuits are moving ... a meeting took place to discuss the next steps ... the court’s mass tort program. Attorneys for the plaintiffs ... at the Complex Litigation Center in Philadelphia’s City Hall ... The Risperdal lawsuits filed against Johnson & Johnson and ...
(Date:9/19/2014)... September 19, 2014 Are you tired ... of problems with seasonal allergies or sinus congestion? Fortunately, ... better alternative. , She conceived of Nose Pal ... a runny nose in public. Since it prevents nasal ... more sanitary conditions, particularly when cooking or working closely ...
Breaking Medicine News(10 mins):Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2
... determine how arsenic increases the risk of lung cancer ... researcher will use $1.7 million in federal funding during ... disrupt cells, leading to the disease. Chengfeng Yang, ... Medicine and MSU,s Center for Integrative Toxicology, will be ...
... National Medical Center, in partnership with The George ... and Translational Science Award (CTSA) from the National Center ... This award, which totals $20 million over ... a children,s hospital. The Clinical and Translational Science ...
... morbidly obese diabetics is causing more new cases of a ... make walking difficult or impossible, and in severe cases can ... bones with an external frame has enabled more than 90 ... University Health System foot and ankle surgeon Dr. Michael Pinzur. ...
... New and updated guidelines on recommended vitamin D intake have ... Canadian Medical Association Journal ( CMAJ ). ... of Medicine, and member of Osteoporosis Canada,s (OC) Scientific Advisory ... of Osteoporosis Canada. "OC,s current recommendations on vitamin D ...
... Kathleen Doheny HealthDay Reporter , TUESDAY, July 13 ... will last ",til death do you part" -- or if ... association game may reveal the hidden truth about your union, ... is flawed because it relies on asking the people involved ...
... common ― and often ineffective ― ways of fighting ... new study from Tel Aviv University shows why they,re ... psychologically-based smoking cessation programs. In the new study ... Dr. Reuven Dar of Tel Aviv University,s Department of ...
Cached Medicine News:Health News:Researcher targets gene regulators on link between arsenic, cancer 2Health News:Children's National Medical Center receives first NIH CTSA given to a children's hospital 2Health News:Children's National Medical Center receives first NIH CTSA given to a children's hospital 3Health News:New treatment for crippling diabetic Charcot foot 2Health News:New vitamin D guidelines 2Health News:Word Games May Predict Life of Relationship 2Health News:Word Games May Predict Life of Relationship 3Health News:Smoking mind over smoking matter 2Health News:Smoking mind over smoking matter 3
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
1.5 mm long blade. Square handle....
3 mm diameter roller blade in line with handle. Curved shaft. Flat handle. 15 mm from curve to tip....
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
Medicine Products: